Open-mkt buys · 90d
—
0 trades · 0 insiders
Open-mkt sales · 90d
—
0 trades · 0 insiders
Net · 90d
$0
Insiders on file
26
Daily buy vs sell · 90 days
No data yet.
Insiders
| Insider | Role | Trades | Bought | Sold | Last trade |
|---|---|---|---|---|---|
| TIMMINS MEGAN C. | General Counsel | 10 | $0 | $0 | 2019-03-26 |
| Shea Patrick M | Chief Commercial Officer | 16 | $0 | $24.4K | 2019-03-26 |
| Strobeck Mark | Chief Operating Officer | 33 | $0 | $949.5K | 2019-03-26 |
| Radie Robert S | President and CEO | 42 | $0 | $1.85M | 2019-03-26 |
| Smiley Andrea Heslin | Director | 4 | $0 | $0 | 2019-01-31 |
| Hochberg Elaine | Director | 4 | $0 | $0 | 2019-01-31 |
| NICOLAIDES NICHOLAS C | Director | 10 | $0 | $0 | 2019-01-31 |
| CARLIN BARBARA | Chief Accounting Officer | 12 | $0 | $0 | 2019-01-31 |
| Varian John | Director | 2 | $0 | $0 | 2019-01-31 |
| Walbert Timothy P | Director | 14 | $0 | $0 | 2019-01-31 |
| WEAVER GREGORY L | Director | 14 | $0 | $0 | 2019-01-31 |
| ROCHE ROBERT P JR | Director | 6 | $0 | $0 | 2019-01-31 |
| OSBORN JOHN E | Director | 10 | $0 | $0 | 2019-01-31 |
| Musial Stan | Chief Financial Officer | 22 | $0 | $838.0K | 2018-06-13 |
| VARKI PAUL | SVP, GC & Chief Compliance Off | 6 | $0 | $18.3K | 2017-07-03 |
| Dayno Jeffrey M. | Chief Medical Officer | 15 | $0 | $57.9K | 2017-06-08 |
| Melloy Deanne F. | Chief Commercial Officer | 7 | $0 | $72.2K | 2016-04-05 |
| LINDHARDT KARSTEN | VP, Research & Development | 3 | $0 | $0 | 2016-01-04 |
| AGUIAR-LUCANDER RENEE | Director | 5 | $1000.0K | $0 | 2014-02-11 |
| Danish Biotech SPV I P/S | 10% Owner | 18 | $2.87M | $0 | 2014-02-11 |
| SEGERROS ANDREAS Rutger | Director, 10% Owner | 11 | $1.60M | $0 | 2014-02-11 |
| SUNSTONE LIFE SCIENCE VENTURES FUND II K/S | 10% Owner | 11 | $1.60M | $0 | 2014-02-11 |
| Index Ventures III Parallel Entrepreneur Fund (Jersey) L.P. | 10% Owner | 5 | $4.45M | $0 | 2014-02-11 |
| Index Ventures III (Delaware) L.P. | 10% Owner | 52 | $0 | $0 | 2014-02-11 |
| Atlas Venture Fund VII L P | 10% Owner | 11 | $500.0K | $0 | 2014-02-11 |
| FORMELA JEAN FRANCOIS | Director, 10% Owner | 11 | $500.0K | $0 | 2014-02-11 |
Trade history
| Insider | Role | Code | Trade | Filed | Shares | Price | Value | Owned after | |
|---|---|---|---|---|---|---|---|---|---|
| Radie Robert S | President and CEO | A Award | 2019-03-26 | 2019-03-28 | 172,000 | — | $0 | 172,000 | SEC↗ |
| Radie Robert S | President and CEO | A Award | 2019-03-26 | 2019-03-28 | 66,000 | — | $0 | 238,000 | SEC↗ |
| Strobeck Mark | Chief Operating Officer | A Award | 2019-03-26 | 2019-03-28 | 87,000 | — | $0 | 87,000 | SEC↗ |
| Strobeck Mark | Chief Operating Officer | A Award | 2019-03-26 | 2019-03-28 | 33,000 | — | $0 | 120,000 | SEC↗ |
| Shea Patrick M | Chief Commercial Officer | A Award | 2019-03-26 | 2019-03-28 | 25,000 | — | $0 | 90,000 | SEC↗ |
| Shea Patrick M | Chief Commercial Officer | A Award | 2019-03-26 | 2019-03-28 | 65,000 | — | $0 | 65,000 | SEC↗ |
| TIMMINS MEGAN C. | General Counsel | A Award | 2019-03-26 | 2019-03-28 | 43,000 | — | $0 | 43,000 | SEC↗ |
| TIMMINS MEGAN C. | General Counsel | A Award | 2019-03-26 | 2019-03-28 | 20,000 | — | $0 | 63,000 | SEC↗ |
| Radie Robert S | President and CEO | D To issuer deriv | 2019-01-31 | 2019-02-04 | 150,000 | — | $0 | 0 | SEC↗ |
| Radie Robert S | President and CEO | D To issuer deriv | 2019-01-31 | 2019-02-04 | 50,000 | — | $0 | 0 | SEC↗ |
| Radie Robert S | President and CEO | D To issuer deriv | 2019-01-31 | 2019-02-04 | 100,000 | — | $0 | 0 | SEC↗ |
| Radie Robert S | President and CEO | D To issuer deriv | 2019-01-31 | 2019-02-04 | 150,000 | — | $0 | 0 | SEC↗ |
| Radie Robert S | President and CEO | D To issuer deriv | 2019-01-31 | 2019-02-04 | 265,000 | — | $0 | 0 | SEC↗ |
| Strobeck Mark | Chief Operating Officer | D To issuer deriv | 2019-01-31 | 2019-02-04 | 100,000 | — | $0 | 0 | SEC↗ |
| Strobeck Mark | Chief Operating Officer | D To issuer deriv | 2019-01-31 | 2019-02-04 | 100,000 | — | $0 | 0 | SEC↗ |
| Strobeck Mark | Chief Operating Officer | D To issuer deriv | 2019-01-31 | 2019-02-04 | 115,000 | — | $0 | 0 | SEC↗ |
| Strobeck Mark | Chief Operating Officer | D To issuer deriv | 2019-01-31 | 2019-02-04 | 40,000 | — | $0 | 0 | SEC↗ |
| CARLIN BARBARA | Chief Accounting Officer | D To issuer deriv | 2019-01-31 | 2019-02-04 | 10,000 | — | $0 | 0 | SEC↗ |
| CARLIN BARBARA | Chief Accounting Officer | D To issuer deriv | 2019-01-31 | 2019-02-04 | 44,000 | — | $0 | 0 | SEC↗ |
| CARLIN BARBARA | Chief Accounting Officer | D To issuer deriv | 2019-01-31 | 2019-02-04 | 17,500 | — | $0 | 0 | SEC↗ |
| CARLIN BARBARA | Chief Accounting Officer | D To issuer deriv | 2019-01-31 | 2019-02-04 | 28,000 | — | $0 | 0 | SEC↗ |
| CARLIN BARBARA | Chief Accounting Officer | D To issuer deriv | 2019-01-31 | 2019-02-04 | 30,000 | — | $0 | 0 | SEC↗ |
| TIMMINS MEGAN C. | General Counsel | D To issuer deriv | 2019-01-31 | 2019-02-04 | 15,000 | — | $0 | 0 | SEC↗ |
| TIMMINS MEGAN C. | General Counsel | D To issuer deriv | 2019-01-31 | 2019-02-04 | 10,000 | — | $0 | 0 | SEC↗ |
| TIMMINS MEGAN C. | General Counsel | D To issuer deriv | 2019-01-31 | 2019-02-04 | 4,375 | — | $0 | 0 | SEC↗ |
| TIMMINS MEGAN C. | General Counsel | D To issuer deriv | 2019-01-31 | 2019-02-04 | 8,500 | — | $0 | 0 | SEC↗ |
| Shea Patrick M | Chief Commercial Officer | D To issuer deriv | 2019-01-31 | 2019-02-04 | 80,000 | — | $0 | 0 | SEC↗ |
| Shea Patrick M | Chief Commercial Officer | D To issuer deriv | 2019-01-31 | 2019-02-04 | 80,000 | — | $0 | 0 | SEC↗ |
| Shea Patrick M | Chief Commercial Officer | D To issuer deriv | 2019-01-31 | 2019-02-04 | 127,500 | — | $0 | 0 | SEC↗ |
| Walbert Timothy P | Director | D To issuer deriv | 2019-01-31 | 2019-02-04 | 10,000 | — | $0 | 0 | SEC↗ |
| Walbert Timothy P | Director | D To issuer deriv | 2019-01-31 | 2019-02-04 | 20,000 | — | $0 | 0 | SEC↗ |
| Walbert Timothy P | Director | D To issuer deriv | 2019-01-31 | 2019-02-04 | 667 | — | $0 | 0 | SEC↗ |
| Walbert Timothy P | Director | D To issuer deriv | 2019-01-31 | 2019-02-04 | 1,328 | — | $0 | 0 | SEC↗ |
| Walbert Timothy P | Director | D To issuer deriv | 2019-01-31 | 2019-02-04 | 29,666 | — | $0 | 0 | SEC↗ |
| Walbert Timothy P | Director | D To issuer deriv | 2019-01-31 | 2019-02-04 | 75,000 | — | $0 | 0 | SEC↗ |
| Walbert Timothy P | Director | D To issuer deriv | 2019-01-31 | 2019-02-04 | 58,133 | — | $0 | 0 | SEC↗ |
| Varian John | Director | D To issuer deriv | 2019-01-31 | 2019-02-04 | 110,000 | — | $0 | 0 | SEC↗ |
| Smiley Andrea Heslin | Director | D To issuer deriv | 2019-01-31 | 2019-02-04 | 75,000 | — | $0 | 0 | SEC↗ |
| Smiley Andrea Heslin | Director | D To issuer deriv | 2019-01-31 | 2019-02-04 | 51,817 | — | $0 | 0 | SEC↗ |
| Hochberg Elaine | Director | D To issuer deriv | 2019-01-31 | 2019-02-04 | 75,000 | — | $0 | 0 | SEC↗ |
| Hochberg Elaine | Director | D To issuer deriv | 2019-01-31 | 2019-02-04 | 51,817 | — | $0 | 0 | SEC↗ |
| OSBORN JOHN E | Director | D To issuer deriv | 2019-01-31 | 2019-02-04 | 75,000 | — | $0 | 0 | SEC↗ |
| OSBORN JOHN E | Director | D To issuer deriv | 2019-01-31 | 2019-02-04 | 20,000 | — | $0 | 0 | SEC↗ |
| OSBORN JOHN E | Director | D To issuer deriv | 2019-01-31 | 2019-02-04 | 10,000 | — | $0 | 0 | SEC↗ |
| OSBORN JOHN E | Director | D To issuer deriv | 2019-01-31 | 2019-02-04 | 29,666 | — | $0 | 0 | SEC↗ |
| OSBORN JOHN E | Director | D To issuer deriv | 2019-01-31 | 2019-02-04 | 58,133 | — | $0 | 0 | SEC↗ |
| WEAVER GREGORY L | Director | D To issuer deriv | 2019-01-31 | 2019-02-04 | 10,000 | — | $0 | 0 | SEC↗ |
| WEAVER GREGORY L | Director | D To issuer deriv | 2019-01-31 | 2019-02-04 | 667 | — | $0 | 0 | SEC↗ |
| WEAVER GREGORY L | Director | D To issuer deriv | 2019-01-31 | 2019-02-04 | 2,083 | — | $0 | 0 | SEC↗ |
| WEAVER GREGORY L | Director | D To issuer deriv | 2019-01-31 | 2019-02-04 | 20,000 | — | $0 | 0 | SEC↗ |
| WEAVER GREGORY L | Director | D To issuer deriv | 2019-01-31 | 2019-02-04 | 75,000 | — | $0 | 0 | SEC↗ |
| WEAVER GREGORY L | Director | D To issuer deriv | 2019-01-31 | 2019-02-04 | 58,133 | — | $0 | 0 | SEC↗ |
| WEAVER GREGORY L | Director | D To issuer deriv | 2019-01-31 | 2019-02-04 | 29,666 | — | $0 | 0 | SEC↗ |
| NICOLAIDES NICHOLAS C | Director | D To issuer deriv | 2019-01-31 | 2019-02-04 | 10,000 | — | $0 | 0 | SEC↗ |
| NICOLAIDES NICHOLAS C | Director | D To issuer deriv | 2019-01-31 | 2019-02-04 | 20,000 | — | $0 | 0 | SEC↗ |
| NICOLAIDES NICHOLAS C | Director | D To issuer deriv | 2019-01-31 | 2019-02-04 | 29,666 | — | $0 | 0 | SEC↗ |
| NICOLAIDES NICHOLAS C | Director | D To issuer deriv | 2019-01-31 | 2019-02-04 | 58,133 | — | $0 | 0 | SEC↗ |
| NICOLAIDES NICHOLAS C | Director | D To issuer deriv | 2019-01-31 | 2019-02-04 | 75,000 | — | $0 | 0 | SEC↗ |
| ROCHE ROBERT P JR | Director | D To issuer deriv | 2019-01-31 | 2019-02-04 | 26,282 | — | $0 | 0 | SEC↗ |
| ROCHE ROBERT P JR | Director | D To issuer deriv | 2019-01-31 | 2019-02-04 | 75,000 | — | $0 | 0 | SEC↗ |
| ROCHE ROBERT P JR | Director | D To issuer deriv | 2019-01-31 | 2019-02-04 | 58,133 | — | $0 | 0 | SEC↗ |
| Radie Robert S | President and CEO | D To issuer | 2019-01-31 | 2019-02-04 | 834,900 | — | $0 | 0 | SEC↗ |
| Radie Robert S | President and CEO | D To issuer | 2019-01-31 | 2019-02-04 | 100,000 | — | $0 | 0 | SEC↗ |
| Strobeck Mark | Chief Operating Officer | D To issuer | 2019-01-31 | 2019-02-04 | 80,000 | — | $0 | 0 | SEC↗ |
| Strobeck Mark | Chief Operating Officer | D To issuer | 2019-01-31 | 2019-02-04 | 237,080 | — | $0 | 0 | SEC↗ |
| CARLIN BARBARA | Chief Accounting Officer | D To issuer | 2019-01-31 | 2019-02-04 | 80,000 | — | $0 | 0 | SEC↗ |
| CARLIN BARBARA | Chief Accounting Officer | D To issuer | 2019-01-31 | 2019-02-04 | 105,923 | — | $0 | 0 | SEC↗ |
| TIMMINS MEGAN C. | General Counsel | D To issuer | 2019-01-31 | 2019-02-04 | 80,000 | — | $0 | 0 | SEC↗ |
| TIMMINS MEGAN C. | General Counsel | D To issuer | 2019-01-31 | 2019-02-04 | 126,500 | — | $0 | 0 | SEC↗ |
| Shea Patrick M | Chief Commercial Officer | D To issuer | 2019-01-31 | 2019-02-04 | 187,020 | — | $0 | 0 | SEC↗ |
| Shea Patrick M | Chief Commercial Officer | D To issuer | 2019-01-31 | 2019-02-04 | 80,000 | — | $0 | 0 | SEC↗ |
| Walbert Timothy P | Director | D To issuer | 2019-01-31 | 2019-02-04 | 150 | — | $0 | 0 | SEC↗ |
| Varian John | Director | A Award deriv | 2018-07-02 | 2018-07-02 | 110,000 | — | $0 | 110,000 | SEC↗ |
| Radie Robert S | President and CEO | A Award | 2018-06-13 | 2018-06-15 | 500,000 | — | $0 | 834,900 | SEC↗ |
| Musial Stan | Chief Financial Officer | A Award | 2018-06-13 | 2018-06-15 | 225,000 | — | $0 | 347,407 | SEC↗ |
| Strobeck Mark | Chief Operating Officer | A Award | 2018-06-13 | 2018-06-15 | 225,000 | — | $0 | 317,080 | SEC↗ |
| Shea Patrick M | Chief Commercial Officer | A Award | 2018-06-13 | 2018-06-15 | 150,000 | — | $0 | 267,020 | SEC↗ |
| TIMMINS MEGAN C. | General Counsel | A Award | 2018-06-13 | 2018-06-15 | 125,000 | — | $0 | 206,500 | SEC↗ |
| CARLIN BARBARA | Chief Accounting Officer | A Award | 2018-06-13 | 2018-06-15 | 100,000 | — | $0 | 185,923 | SEC↗ |
| NICOLAIDES NICHOLAS C | Director | A Award deriv | 2018-05-14 | 2018-05-15 | 75,000 | — | $0 | 75,000 | SEC↗ |
| Hochberg Elaine | Director | A Award deriv | 2018-05-14 | 2018-05-15 | 75,000 | — | $0 | 75,000 | SEC↗ |
| ROCHE ROBERT P JR | Director | A Award deriv | 2018-05-14 | 2018-05-15 | 75,000 | — | $0 | 75,000 | SEC↗ |
| Smiley Andrea Heslin | Director | A Award deriv | 2018-05-14 | 2018-05-15 | 75,000 | — | $0 | 75,000 | SEC↗ |
| OSBORN JOHN E | Director | A Award deriv | 2018-05-14 | 2018-05-15 | 75,000 | — | $0 | 75,000 | SEC↗ |
| Walbert Timothy P | Director | A Award deriv | 2018-05-14 | 2018-05-15 | 75,000 | — | $0 | 75,000 | SEC↗ |
| WEAVER GREGORY L | Director | A Award deriv | 2018-05-14 | 2018-05-15 | 75,000 | — | $0 | 75,000 | SEC↗ |
| TIMMINS MEGAN C. | General Counsel | A Award | 2018-03-06 | 2018-03-08 | 80,000 | — | $0 | 81,500 | SEC↗ |
| Radie Robert S | President and CEO | A Award | 2018-03-06 | 2018-03-08 | 100,000 | — | $0 | 334,900 | SEC↗ |
| Musial Stan | Chief Financial Officer | A Award | 2018-03-06 | 2018-03-08 | 80,000 | — | $0 | 122,407 | SEC↗ |
| Strobeck Mark | Chief Operating Officer | A Award | 2018-03-06 | 2018-03-08 | 80,000 | — | $0 | 92,080 | SEC↗ |
| Shea Patrick M | Chief Commercial Officer | A Award | 2018-03-06 | 2018-03-08 | 80,000 | — | $0 | 117,020 | SEC↗ |
| CARLIN BARBARA | Chief Accounting Officer | A Award | 2018-03-06 | 2018-03-08 | 80,000 | — | $0 | 85,923 | SEC↗ |
| Shea Patrick M | Chief Commercial Officer | S Sale | 2018-01-02 | 2018-01-03 | 910 | $1.00 | $910 | 37,020 | SEC↗ |
| Shea Patrick M | Chief Commercial Officer | S Sale | 2017-10-02 | 2017-10-03 | 910 | $1.30 | $1.2K | 37,930 | SEC↗ |
| Strobeck Mark | Chief Operating Officer | S Sale | 2017-10-02 | 2017-10-03 | 8,700 | $1.29 | $11.2K | 12,080 | SEC↗ |
| VARKI PAUL | SVP, GC & Chief Compliance O | S Sale | 2017-07-03 | 2017-07-06 | 806 | $2.35 | $1.9K | 29,514 | SEC↗ |
| Shea Patrick M | Chief Commercial Officer | S Sale | 2017-07-03 | 2017-07-06 | 910 | $2.35 | $2.1K | 38,840 | SEC↗ |
| Musial Stan | Chief Financial Officer | S Sale | 2017-07-03 | 2017-07-06 | 3,480 | $2.36 | $8.2K | 42,407 | SEC↗ |
| Strobeck Mark | Chief Operating Officer | S Sale | 2017-06-30 | 2017-07-05 | 8,700 | $2.39 | $20.8K | 20,780 | SEC↗ |
| Walbert Timothy P | Director | A Award deriv | 2017-06-08 | 2017-06-12 | 58,133 | — | $0 | 58,133 | SEC↗ |
| NICOLAIDES NICHOLAS C | Director | A Award deriv | 2017-06-08 | 2017-06-12 | 58,133 | — | $0 | 58,133 | SEC↗ |
| OSBORN JOHN E | Director | A Award deriv | 2017-06-08 | 2017-06-12 | 58,133 | — | $0 | 58,133 | SEC↗ |
| ROCHE ROBERT P JR | Director | A Award deriv | 2017-06-08 | 2017-06-12 | 58,133 | — | $0 | 58,133 | SEC↗ |
| WEAVER GREGORY L | Director | A Award deriv | 2017-06-08 | 2017-06-12 | 58,133 | — | $0 | 58,133 | SEC↗ |
| Radie Robert S | President and CEO | A Award deriv | 2017-06-08 | 2017-06-12 | 150,000 | — | $0 | 150,000 | SEC↗ |
| Musial Stan | Chief Financial Officer | A Award deriv | 2017-06-08 | 2017-06-12 | 100,000 | — | $0 | 100,000 | SEC↗ |
| Strobeck Mark | Chief Operating Officer | A Award deriv | 2017-06-08 | 2017-06-12 | 100,000 | — | $0 | 100,000 | SEC↗ |
| Dayno Jeffrey M. | Chief Medical Officer | A Award deriv | 2017-06-08 | 2017-06-12 | 80,000 | — | $0 | 80,000 | SEC↗ |
| Shea Patrick M | Chief Commercial Officer | A Award deriv | 2017-06-08 | 2017-06-12 | 80,000 | — | $0 | 80,000 | SEC↗ |
| VARKI PAUL | SVP, GC & Chief Compliance O | A Award deriv | 2017-06-08 | 2017-06-12 | 50,000 | — | $0 | 50,000 | SEC↗ |
| CARLIN BARBARA | Chief Accounting Officer | A Award deriv | 2017-06-08 | 2017-06-12 | 30,000 | — | $0 | 30,000 | SEC↗ |
| Smiley Andrea Heslin | Director | A Award deriv | 2017-05-01 | 2017-05-02 | 51,817 | — | $0 | 51,817 | SEC↗ |
| Hochberg Elaine | Director | A Award deriv | 2017-05-01 | 2017-05-02 | 51,817 | — | $0 | 51,817 | SEC↗ |
| VARKI PAUL | SVP, GC & Chief Compliance O | S Sale | 2017-04-03 | 2017-04-04 | 806 | $5.05 | $4.1K | 28,820 | SEC↗ |
| Musial Stan | Chief Financial Officer | S Sale | 2017-04-03 | 2017-04-05 | 8,613 | $5.04 | $43.4K | 45,887 | SEC↗ |
| Dayno Jeffrey M. | Chief Medical Officer | S Sale | 2017-03-31 | 2017-04-04 | 536 | $5.16 | $2.8K | 18,212 | SEC↗ |
| Strobeck Mark | Chief Operating Officer | S Sale | 2017-03-31 | 2017-03-31 | 8,700 | $5.11 | $44.5K | 29,480 | SEC↗ |
| Shea Patrick M | Chief Commercial Officer | S Sale | 2017-03-20 | 2017-03-21 | 4,250 | $4.75 | $20.2K | 38,250 | SEC↗ |
| ROCHE ROBERT P JR | Director | A Award deriv | 2017-01-03 | 2017-01-04 | 26,282 | — | $0 | 26,282 | SEC↗ |
| Musial Stan | Chief Financial Officer | S Sale | 2017-01-03 | 2017-01-04 | 13,480 | $7.73 | $104.2K | 54,500 | SEC↗ |
| VARKI PAUL | SVP, GC & Chief Compliance O | S Sale | 2017-01-03 | 2017-01-04 | 806 | $7.75 | $6.2K | 29,626 | SEC↗ |
| Dayno Jeffrey M. | Chief Medical Officer | S Sale | 2017-01-03 | 2017-01-04 | 536 | $7.75 | $4.2K | 18,748 | SEC↗ |
| Strobeck Mark | Chief Operating Officer | S Sale | 2016-12-30 | 2017-01-04 | 8,700 | $7.81 | $67.9K | 38,180 | SEC↗ |
| CARLIN BARBARA | Chief Accounting Officer | A Award deriv | 2016-12-20 | 2016-12-20 | 28,500 | — | $0 | 28,500 | SEC↗ |
| Radie Robert S | President and CEO | A Award deriv | 2016-12-12 | 2016-12-13 | 50,000 | — | $0 | 50,000 | SEC↗ |
| Radie Robert S | President and CEO | A Award deriv | 2016-12-06 | 2016-12-08 | 150,000 | — | $0 | 150,000 | SEC↗ |
| Musial Stan | Chief Financial Officer | A Award deriv | 2016-12-06 | 2016-12-08 | 100,000 | — | $0 | 100,000 | SEC↗ |
| Strobeck Mark | Chief Operating Officer | A Award deriv | 2016-12-06 | 2016-12-08 | 100,000 | — | $0 | 100,000 | SEC↗ |
| Dayno Jeffrey M. | Chief Medical Officer | A Award deriv | 2016-12-06 | 2016-12-08 | 80,000 | — | $0 | 80,000 | SEC↗ |
| Shea Patrick M | Chief Commercial Officer | A Award deriv | 2016-12-06 | 2016-12-08 | 80,000 | — | $0 | 80,000 | SEC↗ |
| VARKI PAUL | SVP, GC & Chief Compliance O | A Award deriv | 2016-12-06 | 2016-12-08 | 50,000 | — | $0 | 50,000 | SEC↗ |
| Shea Patrick M | Chief Commercial Officer | A Award deriv | 2016-10-03 | 2016-10-04 | 127,500 | — | $0 | 127,500 | SEC↗ |
| Musial Stan | Chief Financial Officer | S Sale | 2016-10-03 | 2016-10-04 | 13,480 | $7.47 | $100.7K | 67,980 | SEC↗ |
| Radie Robert S | President and CEO | S Sale | 2016-10-03 | 2016-10-04 | 15,000 | $7.47 | $112.0K | 234,900 | SEC↗ |
| VARKI PAUL | SVP, GC & Chief Compliance O | S Sale | 2016-10-03 | 2016-10-04 | 806 | $7.56 | $6.1K | 30,432 | SEC↗ |
| Dayno Jeffrey M. | Chief Medical Officer | S Sale | 2016-09-30 | 2016-10-03 | 536 | $7.69 | $4.1K | 19,284 | SEC↗ |
| Strobeck Mark | Chief Operating Officer | S Sale | 2016-09-30 | 2016-10-03 | 8,700 | $7.55 | $65.7K | 71,880 | SEC↗ |
| Strobeck Mark | Chief Operating Officer | S Sale | 2016-09-30 | 2016-10-03 | 25,000 | $7.59 | $189.8K | 46,880 | SEC↗ |
| Radie Robert S | President and CEO | S Sale | 2016-07-06 | 2016-07-06 | 5,000 | $5.02 | $25.1K | 249,900 | SEC↗ |
| Musial Stan | Chief Financial Officer | S Sale | 2016-07-05 | 2016-07-06 | 3,480 | $5.05 | $17.6K | 81,460 | SEC↗ |
| Radie Robert S | President and CEO | S Sale | 2016-07-05 | 2016-07-06 | 5,000 | $4.94 | $24.7K | 254,900 | SEC↗ |
| Musial Stan | Chief Financial Officer | S Sale | 2016-07-01 | 2016-07-06 | 10,000 | $5.06 | $50.6K | 84,940 | SEC↗ |
| Radie Robert S | President and CEO | S Sale | 2016-07-01 | 2016-07-06 | 5,000 | $5.07 | $25.4K | 259,900 | SEC↗ |
| Dayno Jeffrey M. | Chief Medical Officer | S Sale | 2016-06-30 | 2016-07-05 | 536 | $4.65 | $2.5K | 19,820 | SEC↗ |
| Strobeck Mark | Chief Business Officer | S Sale | 2016-06-30 | 2016-07-05 | 8,700 | $4.68 | $40.7K | 80,580 | SEC↗ |
| OSBORN JOHN E | Director | A Award deriv | 2016-06-15 | 2016-07-22 | 29,666 | — | $0 | 29,666 | SEC↗ |
| NICOLAIDES NICHOLAS C | Director | A Award deriv | 2016-06-15 | 2016-07-22 | 29,666 | — | $0 | 29,666 | SEC↗ |
| Radie Robert S | President and CEO | A Award deriv | 2016-06-15 | 2016-06-17 | 265,000 | $8.59 | $2.28M | 265,000 | SEC↗ |
| WEAVER GREGORY L | Director | A Award deriv | 2016-06-15 | 2016-06-17 | 29,666 | $4.98 | $147.7K | 29,666 | SEC↗ |
| Walbert Timothy P | Director | A Award deriv | 2016-06-15 | 2016-06-17 | 29,666 | $4.98 | $147.7K | 29,666 | SEC↗ |
| Melloy Deanne F. | Chief Commercial Officer | S Sale | 2016-04-05 | 2016-04-06 | 860 | $6.96 | $6.0K | 33,420 | SEC↗ |
| Radie Robert S | President and CEO | S Sale | 2016-04-05 | 2016-04-06 | 5,000 | $6.99 | $35.0K | 264,900 | SEC↗ |
| Radie Robert S | President and CEO | S Sale | 2016-04-04 | 2016-04-05 | 5,000 | $6.99 | $35.0K | 269,900 | SEC↗ |
| Musial Stan | Chief Financial Officer | S Sale | 2016-04-01 | 2016-04-04 | 3,480 | $7.02 | $24.4K | 94,940 | SEC↗ |
| Musial Stan | Chief Financial Officer | S Sale | 2016-04-01 | 2016-04-04 | 3,480 | $7.02 | $24.4K | 94,940 | SEC↗ |
| Radie Robert S | President and CEO | S Sale | 2016-04-01 | 2016-04-05 | 5,000 | $6.94 | $34.7K | 274,900 | SEC↗ |
| Strobeck Mark | Chief Business Officer | S Sale | 2016-03-31 | 2016-04-04 | 8,700 | $6.70 | $58.3K | 89,280 | SEC↗ |
| Dayno Jeffrey M. | Chief Medical Officer | S Sale | 2016-03-31 | 2016-04-04 | 536 | $6.72 | $3.6K | 20,356 | SEC↗ |
| Radie Robert S | President and CEO | S Sale | 2016-01-11 | 2016-01-12 | 3,000 | $9.65 | $28.9K | 279,900 | SEC↗ |
| Radie Robert S | President and CEO | S Sale | 2016-01-08 | 2016-01-12 | 4,000 | $9.69 | $38.8K | 282,900 | SEC↗ |
| Radie Robert S | President and CEO | S Sale | 2016-01-07 | 2016-01-12 | 3,000 | $9.61 | $28.8K | 286,900 | SEC↗ |
| Radie Robert S | President and CEO | S Sale | 2016-01-06 | 2016-01-07 | 2,100 | $10.16 | $21.3K | 298,900 | SEC↗ |
| Radie Robert S | President and CEO | S Sale | 2016-01-05 | 2016-01-07 | 1,400 | $11.11 | $15.6K | 301,000 | SEC↗ |
| LINDHARDT KARSTEN | VP, Research & Development | A Award deriv | 2016-01-04 | 2016-07-06 | 40,000 | $10.98 | $439.2K | 40,000 | SEC↗ |
| CARLIN BARBARA | Chief Accounting Officer | A Award deriv | 2016-01-04 | 2016-01-11 | 17,500 | — | $0 | 17,500 | SEC↗ |
| Musial Stan | Chief Financial Officer | S Sale | 2016-01-04 | 2016-01-05 | 3,480 | $10.68 | $37.2K | 98,420 | SEC↗ |
| Melloy Deanne F. | Chief Commercial Officer | S Sale | 2016-01-04 | 2016-01-05 | 860 | $10.45 | $9.0K | 34,280 | SEC↗ |
| Radie Robert S | President and CEO | S Sale | 2016-01-04 | 2016-01-07 | 1,500 | $10.47 | $15.7K | 302,400 | SEC↗ |
| Dayno Jeffrey M. | Chief Medical Officer | S Sale | 2015-12-31 | 2016-01-05 | 536 | $10.40 | $5.6K | 20,892 | SEC↗ |
| Strobeck Mark | Chief Business Officer | S Sale | 2015-12-31 | 2016-01-05 | 8,700 | $10.40 | $90.5K | 97,980 | SEC↗ |
| Musial Stan | Chief Financial Officer | A Award deriv | 2015-11-20 | 2015-11-24 | 115,000 | — | $0 | 115,000 | SEC↗ |
| Strobeck Mark | Chief Business Officer | A Award deriv | 2015-11-20 | 2015-11-24 | 115,000 | — | $0 | 115,000 | SEC↗ |
| Dayno Jeffrey M. | Chief Medical Officer | A Award deriv | 2015-11-20 | 2015-11-24 | 100,000 | — | $0 | 100,000 | SEC↗ |
| Melloy Deanne F. | Chief Commercial Officer | A Award deriv | 2015-11-20 | 2015-11-24 | 65,000 | — | $0 | 65,000 | SEC↗ |
| Dayno Jeffrey M. | Chief Medical Officer | S Sale | 2015-10-26 | 2015-10-28 | 536 | $8.96 | $4.8K | 21,428 | SEC↗ |
| Melloy Deanne F. | Chief Commercial Officer | S Sale | 2015-10-06 | 2015-10-07 | 860 | $11.42 | $9.8K | 35,140 | SEC↗ |
| Radie Robert S | President and CEO | S Sale | 2015-10-01 | 2015-10-02 | 15,000 | $12.27 | $184.1K | 303,900 | SEC↗ |
| Musial Stan | Chief Financial Officer | S Sale | 2015-10-01 | 2015-10-02 | 8,480 | $12.32 | $104.5K | 101,900 | SEC↗ |
| Strobeck Mark | Chief Business Officer | S Sale | 2015-09-30 | 2015-10-02 | 5,220 | $12.56 | $65.6K | 106,680 | SEC↗ |
| Melloy Deanne F. | Chief Commercial Officer | S Sale | 2015-07-13 | 2015-09-11 | 4,000 | $11.85 | $47.4K | 36,000 | SEC↗ |
| Radie Robert S | President and CEO | S Sale | 2015-07-08 | 2015-07-09 | 3,000 | $11.62 | $34.9K | 318,900 | SEC↗ |
| Radie Robert S | President and CEO | S Sale | 2015-07-07 | 2015-07-09 | 3,000 | $12.31 | $36.9K | 321,900 | SEC↗ |
| Radie Robert S | President and CEO | S Sale | 2015-07-06 | 2015-07-06 | 3,000 | $11.94 | $35.8K | 324,900 | SEC↗ |
| Radie Robert S | President and CEO | S Sale | 2015-07-02 | 2015-07-06 | 3,000 | $12.44 | $37.3K | 327,900 | SEC↗ |
| Musial Stan | Chief Financial Officer | S Sale | 2015-07-01 | 2015-07-02 | 8,480 | $13.20 | $111.9K | 110,380 | SEC↗ |
| Strobeck Mark | Chief Business Officer | S Sale | 2015-07-01 | 2015-07-02 | 10,440 | $12.98 | $135.5K | 111,900 | SEC↗ |
| Radie Robert S | President and CEO | S Sale | 2015-07-01 | 2015-07-06 | 3,000 | $13.22 | $39.7K | 330,900 | SEC↗ |
| Dayno Jeffrey M. | Chief Medical Officer | S Sale | 2015-06-30 | 2015-07-02 | 536 | $15.32 | $8.2K | 21,964 | SEC↗ |
| OSBORN JOHN E | Director | A Award deriv | 2015-06-10 | 2016-07-22 | 10,000 | — | $0 | 10,000 | SEC↗ |
| NICOLAIDES NICHOLAS C | Director | A Award deriv | 2015-06-10 | 2016-07-22 | 10,000 | — | $0 | 10,000 | SEC↗ |
| Walbert Timothy P | Director | A Award deriv | 2015-06-10 | 2016-06-17 | 10,000 | $12.08 | $120.8K | 10,000 | SEC↗ |
| WEAVER GREGORY L | Director | A Award deriv | 2015-06-10 | 2016-06-17 | 10,000 | $12.08 | $120.8K | 10,000 | SEC↗ |
| OSBORN JOHN E | Director | A Award deriv | 2015-04-10 | 2016-07-22 | 20,000 | — | $0 | 20,000 | SEC↗ |
| NICOLAIDES NICHOLAS C | Director | A Award deriv | 2015-04-10 | 2016-07-22 | 20,000 | — | $0 | 20,000 | SEC↗ |
| Musial Stan | Chief Financial Officer | S Sale | 2015-04-01 | 2015-04-02 | 3,480 | $11.35 | $39.5K | 118,860 | SEC↗ |
| Radie Robert S | President and CEO | S Sale | 2015-04-01 | 2015-04-02 | 11,130 | $11.25 | $125.2K | 333,900 | SEC↗ |
| Dayno Jeffrey M. | Chief Medical Officer | S Sale | 2015-02-03 | 2015-02-03 | 2,500 | $8.87 | $22.2K | 22,500 | SEC↗ |
| Melloy Deanne F. | Chief Commercial Officer | A Award deriv | 2015-01-02 | 2015-01-15 | 120,000 | — | $0 | 120,000 | SEC↗ |
| Strobeck Mark | Chief Business Officer | S Sale | 2015-01-02 | 2015-01-05 | 3,480 | $5.09 | $17.7K | 122,340 | SEC↗ |
| Musial Stan | Chief Financial Officer | S Sale | 2015-01-02 | 2015-01-05 | 3,480 | $5.05 | $17.6K | 122,340 | SEC↗ |
| Radie Robert S | President and CEO | S Sale | 2015-01-02 | 2015-01-05 | 11,130 | $5.11 | $56.9K | 345,030 | SEC↗ |
| Melloy Deanne F. | Chief Commercial Officer | A Award | 2015-01-02 | 2015-01-15 | 40,000 | — | $0 | 40,000 | SEC↗ |
| Radie Robert S | President and CEO | A Award deriv | 2014-12-04 | 2014-12-08 | 100,000 | — | $0 | 100,000 | SEC↗ |
| Musial Stan | Chief Financial Officer | A Award deriv | 2014-12-04 | 2014-12-08 | 40,000 | — | $0 | 40,000 | SEC↗ |
| Dayno Jeffrey M. | Chief Medical Officer | A Award deriv | 2014-12-04 | 2014-12-08 | 60,000 | — | $0 | 60,000 | SEC↗ |
| Strobeck Mark | Chief Business Officer | A Award deriv | 2014-12-04 | 2014-12-08 | 40,000 | — | $0 | 40,000 | SEC↗ |
| LINDHARDT KARSTEN | VP, Research & Development | A Award deriv | 2014-12-04 | 2014-12-08 | 40,000 | — | $0 | 40,000 | SEC↗ |
| Walbert Timothy P | Director | A Award deriv | 2014-09-30 | 2014-10-01 | 20,000 | — | $0 | 20,000 | SEC↗ |
| WEAVER GREGORY L | Director | A Award deriv | 2014-09-30 | 2014-10-01 | 20,000 | — | $0 | 20,000 | SEC↗ |
| Radie Robert S | President and CEO | S Sale | 2014-09-10 | 2014-09-11 | 20,020 | $9.68 | $193.8K | 356,160 | SEC↗ |
| Radie Robert S | President and CEO | S Sale | 2014-09-09 | 2014-09-11 | 20,020 | $9.54 | $191.0K | 376,180 | SEC↗ |
| Radie Robert S | President and CEO | S Sale | 2014-09-08 | 2014-09-09 | 19,000 | $9.66 | $183.5K | 396,200 | SEC↗ |
| Radie Robert S | President and CEO | S Sale | 2014-09-05 | 2014-09-09 | 30,000 | $9.79 | $293.7K | 415,200 | SEC↗ |
| Strobeck Mark | Chief Business Officer | S Sale | 2014-08-13 | 2014-08-14 | 2,635 | $9.15 | $24.1K | 125,280 | SEC↗ |
| Strobeck Mark | Chief Business Officer | S Sale | 2014-08-12 | 2014-08-14 | 2,500 | $9.26 | $23.1K | 127,915 | SEC↗ |
| Strobeck Mark | Chief Business Officer | S Sale | 2014-08-11 | 2014-08-12 | 3,300 | $10.16 | $33.5K | 130,415 | SEC↗ |
| Strobeck Mark | Chief Business Officer | S Sale | 2014-08-08 | 2014-08-12 | 2,400 | $10.45 | $25.1K | 133,715 | SEC↗ |
| Musial Stan | Chief Financial Officer | S Sale | 2014-08-07 | 2014-08-08 | 6,272 | $11.03 | $69.2K | 125,820 | SEC↗ |
| Strobeck Mark | Chief Business Officer | S Sale | 2014-08-07 | 2014-08-08 | 1,200 | $10.90 | $13.1K | 136,115 | SEC↗ |
| Dayno Jeffrey M. | Chief Medical Officer | A Award deriv | 2014-08-06 | 2014-08-07 | 75,000 | — | $0 | 75,000 | SEC↗ |
| Dayno Jeffrey M. | Chief Medical Officer | A Award | 2014-08-06 | 2014-08-07 | 25,000 | — | $0 | 25,000 | SEC↗ |
| Musial Stan | Chief Financial Officer | S Sale | 2014-08-06 | 2014-08-08 | 7,648 | $11.06 | $84.6K | 131,552 | SEC↗ |
| Strobeck Mark | Chief Business Officer | S Sale | 2014-08-06 | 2014-08-08 | 1,885 | $11.89 | $22.4K | 137,315 | SEC↗ |
| WEAVER GREGORY L | Director | A Award deriv | 2014-06-09 | 2014-06-11 | 667 | — | $0 | 667 | SEC↗ |
| Walbert Timothy P | Director | A Award deriv | 2014-06-09 | 2014-06-11 | 667 | — | $0 | 667 | SEC↗ |
| FORMELA JEAN FRANCOIS | Director, 10% Owner | C Conversion deriv | 2014-02-11 | 2014-02-12 | 863,754 | — | $0 | 0 | SEC↗ |
| FORMELA JEAN FRANCOIS | Director, 10% Owner | C Conversion deriv | 2014-02-11 | 2014-02-12 | 833,098 | — | $0 | 0 | SEC↗ |
| FORMELA JEAN FRANCOIS | Director, 10% Owner | C Conversion deriv | 2014-02-11 | 2014-02-12 | 0 | — | $0 | 0 | SEC↗ |
| FORMELA JEAN FRANCOIS | Director, 10% Owner | C Conversion deriv | 2014-02-11 | 2014-02-12 | 0 | — | $0 | 0 | SEC↗ |
| FORMELA JEAN FRANCOIS | Director, 10% Owner | X Exercise deriv | 2014-02-11 | 2014-02-12 | 30,000 | — | $0 | 0 | SEC↗ |
| Atlas Venture Fund VII L P | 10% Owner | X Exercise deriv | 2014-02-11 | 2014-02-12 | 30,000 | — | $0 | 0 | SEC↗ |
| Atlas Venture Fund VII L P | 10% Owner | C Conversion deriv | 2014-02-11 | 2014-02-12 | 0 | — | $0 | 0 | SEC↗ |
| Atlas Venture Fund VII L P | 10% Owner | C Conversion deriv | 2014-02-11 | 2014-02-12 | 0 | — | $0 | 0 | SEC↗ |
| Atlas Venture Fund VII L P | 10% Owner | C Conversion deriv | 2014-02-11 | 2014-02-12 | 863,754 | — | $0 | 0 | SEC↗ |
| Atlas Venture Fund VII L P | 10% Owner | C Conversion deriv | 2014-02-11 | 2014-02-12 | 833,098 | — | $0 | 0 | SEC↗ |
| SUNSTONE LIFE SCIENCE VENTURES | 10% Owner | X Exercise deriv | 2014-02-11 | 2014-02-12 | 96,000 | — | $0 | 0 | SEC↗ |
| SUNSTONE LIFE SCIENCE VENTURES | 10% Owner | C Conversion deriv | 2014-02-11 | 2014-02-12 | 0 | — | $0 | 0 | SEC↗ |
| SUNSTONE LIFE SCIENCE VENTURES | 10% Owner | C Conversion deriv | 2014-02-11 | 2014-02-12 | 0 | — | $0 | 0 | SEC↗ |
| SUNSTONE LIFE SCIENCE VENTURES | 10% Owner | C Conversion deriv | 2014-02-11 | 2014-02-12 | 736,826 | — | $0 | 0 | SEC↗ |
| SUNSTONE LIFE SCIENCE VENTURES | 10% Owner | C Conversion deriv | 2014-02-11 | 2014-02-12 | 416,812 | — | $0 | 0 | SEC↗ |
| SEGERROS ANDREAS Rutger | Director, 10% Owner | C Conversion deriv | 2014-02-11 | 2014-02-12 | 0 | — | $0 | 0 | SEC↗ |
| SEGERROS ANDREAS Rutger | Director, 10% Owner | C Conversion deriv | 2014-02-11 | 2014-02-12 | 416,812 | — | $0 | 0 | SEC↗ |
| SEGERROS ANDREAS Rutger | Director, 10% Owner | C Conversion deriv | 2014-02-11 | 2014-02-12 | 0 | — | $0 | 0 | SEC↗ |
| SEGERROS ANDREAS Rutger | Director, 10% Owner | X Exercise deriv | 2014-02-11 | 2014-02-12 | 96,000 | — | $0 | 0 | SEC↗ |
| SEGERROS ANDREAS Rutger | Director, 10% Owner | C Conversion deriv | 2014-02-11 | 2014-02-12 | 736,826 | — | $0 | 0 | SEC↗ |
| AGUIAR-LUCANDER RENEE | Director | X Exercise deriv | 2014-02-11 | 2014-02-12 | 60,000 | — | $0 | 0 | SEC↗ |
| AGUIAR-LUCANDER RENEE | Director | C Conversion deriv | 2014-02-11 | 2014-02-12 | 0 | — | $0 | 0 | SEC↗ |
| Danish Biotech SPV I P/S | 10% Owner | C Conversion deriv | 2014-02-11 | 2014-02-13 | 251,125 | — | $0 | 0 | SEC↗ |
| Danish Biotech SPV I P/S | 10% Owner | X Exercise deriv | 2014-02-11 | 2014-02-13 | 0 | — | $0 | 0 | SEC↗ |
| Danish Biotech SPV I P/S | 10% Owner | C Conversion deriv | 2014-02-11 | 2014-02-13 | 0 | — | $0 | 0 | SEC↗ |
| Danish Biotech SPV I P/S | 10% Owner | C Conversion deriv | 2014-02-11 | 2014-02-13 | 60,000 | — | $0 | 0 | SEC↗ |
| Danish Biotech SPV I P/S | 10% Owner | X Exercise deriv | 2014-02-11 | 2014-02-13 | 112,500 | — | $0 | 0 | SEC↗ |
| Danish Biotech SPV I P/S | 10% Owner | C Conversion deriv | 2014-02-11 | 2014-02-13 | 0 | — | $0 | 0 | SEC↗ |
| Danish Biotech SPV I P/S | 10% Owner | C Conversion deriv | 2014-02-11 | 2014-02-13 | 438,364 | — | $0 | 0 | SEC↗ |
| Danish Biotech SPV I P/S | 10% Owner | C Conversion deriv | 2014-02-11 | 2014-02-13 | 523,799 | — | $0 | 0 | SEC↗ |
| Index Ventures III (Delaware) | 10% Owner | C Conversion deriv | 2014-02-11 | 2014-02-13 | 5,390 | — | $0 | 0 | SEC↗ |
| Index Ventures III (Delaware) | 10% Owner | C Conversion deriv | 2014-02-11 | 2014-02-13 | 47,298 | — | $0 | 0 | SEC↗ |
| Index Ventures III (Delaware) | 10% Owner | C Conversion deriv | 2014-02-11 | 2014-02-13 | 89,800 | — | $0 | 0 | SEC↗ |
| Index Ventures III (Delaware) | 10% Owner | C Conversion deriv | 2014-02-11 | 2014-02-13 | 169,372 | — | $0 | 0 | SEC↗ |
| Index Ventures III (Delaware) | 10% Owner | C Conversion deriv | 2014-02-11 | 2014-02-13 | 302,576 | — | $0 | 0 | SEC↗ |
| Index Ventures III (Delaware) | 10% Owner | X Exercise deriv | 2014-02-11 | 2014-02-13 | 23,284 | — | $0 | 0 | SEC↗ |
| Index Ventures III (Delaware) | 10% Owner | C Conversion deriv | 2014-02-11 | 2014-02-13 | 44,207 | — | $0 | 0 | SEC↗ |
| Index Ventures III (Delaware) | 10% Owner | C Conversion deriv | 2014-02-11 | 2014-02-13 | 83,377 | — | $0 | 0 | SEC↗ |
| Index Ventures III (Delaware) | 10% Owner | C Conversion deriv | 2014-02-11 | 2014-02-13 | 148,950 | — | $0 | 0 | SEC↗ |
| Index Ventures III (Delaware) | 10% Owner | C Conversion deriv | 2014-02-11 | 2014-02-13 | 3,685 | — | $0 | 0 | SEC↗ |
| Index Ventures III (Delaware) | 10% Owner | C Conversion deriv | 2014-02-11 | 2014-02-13 | 1,600 | — | $0 | 0 | SEC↗ |
| Index Ventures III (Delaware) | 10% Owner | X Exercise deriv | 2014-02-11 | 2014-02-13 | 3,017 | — | $0 | 0 | SEC↗ |
| Index Ventures III (Delaware) | 10% Owner | C Conversion deriv | 2014-02-11 | 2014-02-13 | 0 | — | $0 | 0 | SEC↗ |
| Index Ventures III (Delaware) | 10% Owner | C Conversion deriv | 2014-02-11 | 2014-02-13 | 192,076 | — | $0 | 0 | SEC↗ |
| Index Ventures III (Delaware) | 10% Owner | X Exercise deriv | 2014-02-11 | 2014-02-13 | 3,500 | — | $0 | 0 | SEC↗ |
| Index Ventures III (Delaware) | 10% Owner | C Conversion deriv | 2014-02-11 | 2014-02-13 | 1,093 | — | $0 | 0 | SEC↗ |
| Index Ventures III (Delaware) | 10% Owner | C Conversion deriv | 2014-02-11 | 2014-02-13 | 2,062 | — | $0 | 0 | SEC↗ |
| Index Ventures III (Delaware) | 10% Owner | C Conversion deriv | 2014-02-11 | 2014-02-13 | 0 | — | $0 | 0 | SEC↗ |
| Index Ventures III (Delaware) | 10% Owner | C Conversion deriv | 2014-02-11 | 2014-02-13 | 0 | — | $0 | 0 | SEC↗ |
| Index Ventures III (Delaware) | 10% Owner | C Conversion deriv | 2014-02-11 | 2014-02-13 | 0 | — | $0 | 0 | SEC↗ |
| Index Ventures III (Delaware) | 10% Owner | X Exercise deriv | 2014-02-11 | 2014-02-13 | 0 | — | $0 | 0 | SEC↗ |
| Index Ventures III (Delaware) | 10% Owner | C Conversion deriv | 2014-02-11 | 2014-02-13 | 0 | — | $0 | 0 | SEC↗ |
| Index Ventures III (Delaware) | 10% Owner | C Conversion deriv | 2014-02-11 | 2014-02-13 | 0 | — | $0 | 0 | SEC↗ |
| Index Ventures III (Delaware) | 10% Owner | X Exercise deriv | 2014-02-11 | 2014-02-13 | 0 | — | $0 | 0 | SEC↗ |
| Index Ventures III (Delaware) | 10% Owner | C Conversion deriv | 2014-02-11 | 2014-02-13 | 0 | — | $0 | 0 | SEC↗ |
| Index Ventures III (Delaware) | 10% Owner | C Conversion deriv | 2014-02-11 | 2014-02-13 | 842 | — | $0 | 0 | SEC↗ |
| Radie Robert S | President and CEO | A Award | 2014-02-11 | 2014-02-12 | 445,200 | — | $0 | 445,200 | SEC↗ |
| Musial Stan | Chief Financial Officer | A Award | 2014-02-11 | 2014-02-12 | 139,200 | — | $0 | 139,200 | SEC↗ |
| LINDHARDT KARSTEN | VP, Research & Development | A Award | 2014-02-11 | 2014-02-12 | 139,200 | — | $0 | 139,200 | SEC↗ |
| Strobeck Mark | Chief Business Officer | A Award | 2014-02-11 | 2014-02-12 | 139,200 | — | $0 | 139,200 | SEC↗ |
| FORMELA JEAN FRANCOIS | Director, 10% Owner | C Conversion | 2014-02-11 | 2014-02-12 | 85,620 | $6.00 | $513.7K | 2,110,555 | SEC↗ |
| FORMELA JEAN FRANCOIS | Director, 10% Owner | P Buy | 2014-02-11 | 2014-02-12 | 41,667 | $12.00 | $500.0K | 2,152,222 | SEC↗ |
| FORMELA JEAN FRANCOIS | Director, 10% Owner | C Conversion | 2014-02-11 | 2014-02-12 | 298,083 | $6.00 | $1.79M | 2,024,935 | SEC↗ |
| FORMELA JEAN FRANCOIS | Director, 10% Owner | X Exercise | 2014-02-11 | 2014-02-12 | 30,000 | — | $0 | 1,726,852 | SEC↗ |
| FORMELA JEAN FRANCOIS | Director, 10% Owner | C Conversion | 2014-02-11 | 2014-02-12 | 863,754 | — | $0 | 1,696,852 | SEC↗ |
| FORMELA JEAN FRANCOIS | Director, 10% Owner | C Conversion | 2014-02-11 | 2014-02-12 | 833,098 | — | $0 | 833,098 | SEC↗ |
| Atlas Venture Fund VII L P | 10% Owner | P Buy | 2014-02-11 | 2014-02-12 | 41,667 | $12.00 | $500.0K | 2,152,222 | SEC↗ |
| Atlas Venture Fund VII L P | 10% Owner | C Conversion | 2014-02-11 | 2014-02-12 | 85,620 | $6.00 | $513.7K | 2,110,555 | SEC↗ |
| Atlas Venture Fund VII L P | 10% Owner | C Conversion | 2014-02-11 | 2014-02-12 | 298,083 | $6.00 | $1.79M | 2,024,935 | SEC↗ |
| Atlas Venture Fund VII L P | 10% Owner | X Exercise | 2014-02-11 | 2014-02-12 | 30,000 | — | $0 | 1,726,852 | SEC↗ |
| Atlas Venture Fund VII L P | 10% Owner | C Conversion | 2014-02-11 | 2014-02-12 | 863,754 | — | $0 | 1,696,852 | SEC↗ |
| Atlas Venture Fund VII L P | 10% Owner | C Conversion | 2014-02-11 | 2014-02-12 | 833,098 | — | $0 | 833,098 | SEC↗ |
| SUNSTONE LIFE SCIENCE VENTURES | 10% Owner | X Exercise | 2014-02-11 | 2014-02-12 | 96,000 | — | $0 | 1,249,638 | SEC↗ |
| SUNSTONE LIFE SCIENCE VENTURES | 10% Owner | C Conversion | 2014-02-11 | 2014-02-12 | 736,826 | — | $0 | 1,153,638 | SEC↗ |
| SUNSTONE LIFE SCIENCE VENTURES | 10% Owner | C Conversion | 2014-02-11 | 2014-02-12 | 416,812 | — | $0 | 416,812 | SEC↗ |